Literature DB >> 28947932

Allosteric Modulators of the M4 Muscarinic Acetylcholine Receptor.

Robert B Kargbo1.   

Abstract

Year:  2017        PMID： 28947932      PMCID： PMC5601365          DOI： 10.1021/acsmedchemlett.7b00308

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease.

Authors:  Patrizia Russo; Aliaksei Kisialiou; Rossana Moroni; Giulia Prinzi; Massimo Fini
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 2.  Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.

Authors:  Jianxin Shen; Jie Wu
Journal:  Int Rev Neurobiol       Date:  2015-09-26       Impact factor: 3.230

Review 3.  Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets.

Authors:  Dénes Zádori; Gábor Veres; Levente Szalárdy; Péter Klivényi; József Toldi; László Vécsei
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 4.  The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.

Authors:  Min Xia; Xiaofang Cheng; Ruofan Yi; Dong Gao; Jiaxiang Xiong
Journal:  Mol Neurobiol       Date:  2014-12-04       Impact factor: 5.590

Review 5.  Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication.

Authors:  William James Deardorff; Ahmad Shobassy; George T Grossberg
Journal:  Expert Rev Neurother       Date:  2014-12-15       Impact factor: 4.618
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.